Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Genetics of Keloid Scarring

In: Textbook on Scar Management: State of the Art Management and Emerging Technologies [Internet]. Cham (CH): Springer; 2020. Chapter 8.
.
Affiliations
Free Books & Documents
Review

Genetics of Keloid Scarring

Alia Sadiq et al.
Free Books & Documents

Excerpt

Keloid disease is a benign fibro-proliferative reticular dermal tumor that develops in response to dysregulated cutaneous wound-healing process. The key alterations result in keloid formation have not been fully understood yet.

Extensive literature review suggests that there is a strong genetic predisposition for keloid formation as keloid cases have appeared in twins, families, Asian and African descendant ethnic groups predominantly. Thus, there have been several attempts to investigate the genetic variations that may act as contributing factors in keloid pathogenesis, but no single genetic cause has been identified so far. Gene expression studies have shown highly variable results in linkage analysis of keloid families and in keloid fibroblasts. These findings provide clues that keloids arise from heterogeneous genetic events in coordination with immune-related components for example, the Major Histocompatibility Complex genes, consequently that may contributing towards dermal fibrosis. In addition, it is likely that multiple genetic and epigenetic factors are responsible for the development of the disease pathology. In summary, keloid disease is a disorder in which the exact genetic contribution to pathogenesis is yet to be elucidated. Understanding the genetic basis of keloid disease would help to identify targeted therapies as well as accurately assess individual genetic susceptibility to keloids, in order to provide a more personalized approach to their management.

PubMed Disclaimer

References

    1. N. Jumper, T. Hodgkinson, R. Paus, A. Bayat. Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology. PLoS ONE. 12(3):e0172955. https://doi.org/10.1371/journal.pone.0172955. - DOI - PMC - PubMed
    1. Tabib T, Morse C, Wang T, Chen W, Lafyatis R. SRP2/DPP4 and FMO1/LSP1 Define major fibroblast populations in human skin. J Invest Dermatol. 2018;138(4):802–10. https://doi.org/10.1016/j.jid.2017.09.045 - DOI - PMC - PubMed
    1. Sun HJ, Meng XY, Hu CT. MicroRNA-200c inhibits cell proliferation and collagen synthesis in human keloid fibroblasts via TGF-β/Smad pathway. Chinese J Aesthet Med. 2012;21:1539–42.
    1. Xue Z, Lan D, Ning S, Ran L. miR-183 inhibits connective tissue growth factor (CTGF) production in TGF-β1-treated keloid fibroblasts in vitro. Int J Clin Exp Pathol. 2017;10(6):6425–34.
References
    1. Adhyatmika A, Putri KS, Beljaars L, Melgert BN. The elusive antifibrotic macrophage. Front Med. 2015;2:81. - PMC - PubMed
    1. Ambros V. The functions of animal micrornas. Nature. 2004;431:350–5. - PubMed
    1. Aoki M, Miyake K, Ogawa R, Dohi T, Akaishi S, Hyakusoku H, Shimada T. siRNA knockdown of tissue inhibitor of Metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I. J Invest Dermatol. 2014;134:818–26. - PubMed
    1. Ashcroft KJ, Syed F, Arscott G, Bayat A. Assessment of the influence of HLA class I and class II loci on the prevalence of keloid disease in Jamaican afro-Caribbeans. Tissue Antigens. 2011;78(5):390–6. - PubMed
    1. Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O. Methylation-associated silencing of SFRP1 in renal cell carcinoma. Oncol Rep. 2008;20(5):1257–63. - PubMed

LinkOut - more resources